ঔষধ তালিকায় ফিরুন
Tablet
Certican 050 mg Tablet
Everolimus
ইউনিট মূল্য
৳ ২৫০
পাতা/স্ট্রিপ মূল্য
৳ ২৫০০
পুরো প্যাক মূল্য
৳ ১৫০০০
প্যাক সাইজ
৬ × ১০
ডাক্তারের পরামর্শ
এই ওষুধটি সেবনের আগে অভিজ্ঞ ডাক্তারের পরামর্শ নিন।
Everolimus is a kinase inhibitor indicated for the treatment of: Postmenopausal women with advanced hormone receptor-positive, HER2- negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole. Adults with progressive neuroendocrine tumors of pancreatic origin (PNET) and adults with progressive, well-differentiated, non-functional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin that are unresectable, locally advanced or metastatic. ... Read moreEverolimus is a kinase inhibitor indicated for the treatment of: Postmenopausal women with advanced hormone receptor-positive, HER2- negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole. Adults with progressive neuroendocrine tumors of pancreatic origin (PNET) and adults with progressive, well-differentiated, non-functional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin that are unresectable, locally advanced or metastatic. Adults with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or sorafenib. Adults with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery.
Everolimus are kinase inhibitors indicated for the treatment of adult and pediatric patients aged 1 year and older with TSC who have subependymal giant cell astrocytoma (SEGA) that requires therapeutic intervention but cannot be curatively resected.Everolimus is a kinase inhibitor indicated for the adjunctive treatment of adult and pediatric patients aged 2 years and older with TSC- associated partial-onset seizures.